Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting125%
unknown125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Bronchoscopic Lung Volume Reduction in Management of Localized Emphysema

NCT06629558
unknownnot_applicable

LVRS Versus BLVR in Patients With Homogenous Emphysema, CLUB-HE Trial

NCT04781582
completednot_applicable

A Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System.

NCT02012673
completedphase_2

Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema

NCT02107209

Clinical Trials (4)

Showing 4 of 4 trials
NCT06629558Not Applicable

Bronchoscopic Lung Volume Reduction in Management of Localized Emphysema

Recruiting
NCT04781582Not Applicable

LVRS Versus BLVR in Patients With Homogenous Emphysema, CLUB-HE Trial

Unknown
NCT02012673Not Applicable

A Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System.

Completed
NCT02107209Phase 2

Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4